Paalisbo, Noel I.

HRN: 22-35-95  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2022
CEFTRIAXONE 1G (VIAL)
12/28/2022
01/03/2023
IV
2g
OD
CAP MR
Waiting Final Action 
12/28/2022
AZITHROMYCIN 500MG TABLET (TAB)
12/28/2022
01/03/2023
PO
500mg
OD
CAP MR
Waiting Final Action 
12/29/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/29/2022
01/04/2023
IV
600mg
Q8
Pleural Effusion Sec To Parapneumonic Process Vs Malignant Process; Intraabdominal Mass
Waiting Final Action 
01/02/2023
CEFTAZIDIME 1GM (VIAL)
01/02/2023
01/08/2023
IVTT
2g
Q8
Empyema Thoracis
Waiting Final Action 
01/04/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/04/2023
01/10/2023
IVT
500 Mg
Q6
Massive Hepatic Abscess
Waiting Final Action 
01/14/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/14/2023
01/21/2023
IV
1.5g
Q6
Hepatic Abscess
Waiting Final Action 
01/14/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/14/2023
01/17/2023
IV
750mg
Q8
Hepatic Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: